AAPL 206.98 +2.37 (+1.16%)MSFT 124.94 +1.19 (+0.96%)FB 183.46 +1.67 (+0.92%)ZNGA 5.62 +0.1 (+1.81%)NVDA 191.36 +2.88 (+1.53%)WBA 53.72 -0.38 (-0.69%)GOOG 1266.32 +17.6 (+1.41%)PIH 5.25 -0.05 (-0.94%)
AAPL 206.98 +2.37 (+1.16%)MSFT 124.94 +1.19 (+0.96%)FB 183.46 +1.67 (+0.92%)ZNGA 5.62 +0.1 (+1.81%)NVDA 191.36 +2.88 (+1.53%)WBA 53.72 -0.38 (-0.69%)GOOG 1266.32 +17.6 (+1.41%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet APTO Quote Aptose Bios

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 8 11 15
ShortTermInvest 0 1 0
Cash 8 11 16
AccountReceivab 0 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 8 12 16
PPE 0 0 1
AccumulatedDepr 0 0 0
NetPPE 0 0 0
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 0 0 0
TotalNonCurrent 0 0 0
TotalAssets 9 12 17
ShortTermDebt 0 0 0
AccountsPayable 0 0 1
TaxesPayable 0 0 0
AccruedLiabilit 0 0 1
DeferredRevenue 0 0 0
OtherCurrentLia 1 2 0
TotalCurrentLia 1 2 3
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 0 0
TotalNonCurrent 0 0 0
TotalLiabilitie 1 2 3
CommonStock 0 0 0
AdditionalPaidI 188 255 294
RetainedEarning -187 -247 -276
AccumulatedOthe 6 2 -4
TotalStockholde 7 10 14
TotalLiabilitie 9 12 17
Aptose Biosciences Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Aptose Biosciences Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.